1. Home
  2. IFBD vs SILO Comparison

IFBD vs SILO Comparison

Compare IFBD & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Infobird Co. Ltd

IFBD

Infobird Co. Ltd

HOLD

Current Price

$0.98

Market Cap

8.4M

Sector

Technology

ML Signal

HOLD

Logo Silo Pharma Inc.

SILO

Silo Pharma Inc.

HOLD

Current Price

$0.45

Market Cap

8.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
IFBD
SILO
Founded
2001
2010
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Apparel
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
8.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
IFBD
SILO
Price
$0.98
$0.45
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
14.4K
141.3K
Earning Date
01-01-0001
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,861,442.00
$72,102.00
Revenue This Year
N/A
$1.86
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1520.48
N/A
52 Week Low
$0.88
$0.36
52 Week High
$3.09
$3.37

Technical Indicators

Market Signals
Indicator
IFBD
SILO
Relative Strength Index (RSI) 57.92 44.64
Support Level $0.90 $0.45
Resistance Level $0.99 $0.48
Average True Range (ATR) 0.08 0.03
MACD 0.00 0.01
Stochastic Oscillator 86.46 77.68

Price Performance

Historical Comparison
IFBD
SILO

About IFBD Infobird Co. Ltd

Infobird Co Ltd is engaged in developing and providing customer engagement cloud-based services. It software-as-a-service provider of AI-powered, or artificial intelligence-enabled, customer engagement solutions in China. It provides holistic software solutions to help corporate clients proactively deliver and manage end-to-end customer engagement activities at all stages of the sales process, including pre-sales and sales activities, and post-sales customer support. It also offers AI-powered cloud-based sales force management software, including intelligent quality inspection and intelligent training software to help clients monitor, benchmark, and improve the performance of agents.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Share on Social Networks: